World's Best Scientists 2026 revealed!
Vincenzo Mazzaferro

Vincenzo Mazzaferro

D-Index & Metrics

Medicine

D-Index
111
Citations
103205
World Ranking
5216
National Ranking
166

Overview

Vincenzo Mazzaferro is affiliated with the University of Milan in Italy and has an extensive publication record focused primarily on medicine with particular expertise in hepatology, surgery, and oncology. Their research has contributed to various subfields including hepatology, surgery, oncology, pulmonary and respiratory medicine, and epidemiology.

Key topics in Mazzaferro's work encompass hepatocellular carcinoma treatment and prognosis, cholangiocarcinoma and gallbladder cancer studies, pancreatic and hepatic oncology research, liver disease diagnosis and treatment, organ transplantation techniques and outcomes, liver disease and transplantation, and gastric cancer management and outcomes.

Notable recent papers authored or co-authored by Mazzaferro include:

  • Liver resection and transplantation for intrahepatic cholangiocarcinoma, 2020, Journal of Hepatology
  • Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial, 2020, The Lancet Oncology

Additional influential works in the general scope of their field, though authored by other researchers with significant citations, include:

  • BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update, 2021, Journal of Hepatology
  • Immunotherapies for hepatocellular carcinoma, 2021, Nature Reviews Clinical Oncology
  • EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma, 2024, Journal of Hepatology

Mazzaferro frequently publishes in several key venues related to their specialty. These venues include:

  • Journal of Hepatology
  • Updates in Surgery
  • HPB
  • Annals of Surgery
  • Digestive and Liver Disease

The scientist has collaborated extensively with several frequent co-authors, among them:

  • Carlo Sposito
  • Fabrizio Di Benedetto
  • Luca Aldrighetti
  • Umberto Cillo
  • Salvatore Gruttadauria

The volume of Mazzaferro's work within medicine totals over 600 publications, with a focused contribution of 164 publications in hepatology alone. Their interdisciplinary research spans clinical and surgical approaches to liver diseases, with a strong emphasis on cancer treatment and transplantation outcomes.

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma

    Peter R. Galle;Alejandro Forner;Josep M. Llovet;Vincenzo Mazzaferro

  • Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

    Vincenzo Mazzaferro;Enrico Regalia;Roberto Doci;Salvatore Andreola

  • BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update.

    M. Reig;A. Forner;J. Rimola;J. Ferrer-Fábrega

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Immunotherapies for hepatocellular carcinoma.

    Josep M Llovet;Josep M Llovet;Josep M Llovet;Florian Castet;Mathias Heikenwalder;Mala K Maini

  • Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

    Kornelius Schulze;Sandrine Imbeaud;Eric Letouzé;Ludmil B. Alexandrov;Ludmil B. Alexandrov

  • Hepatocellular carcinoma: clinical frontiers and perspectives

    Jordi Bruix;Gregory J Gores;Vincenzo Mazzaferro

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Resection and liver transplantation for hepatocellular carcinoma.

    Josep M. Llovet;Myron Schwartz;Vincenzo Mazzaferro

  • Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

    Jordi Bruix;Tadatoshi Takayama;Vincenzo Mazzaferro;Gar Yang Chau

  • miR-221 overexpression contributes to liver tumorigenesis

    Pascal Pineau;Stefano Volinia;Katherine McJunkin;Agnès Marchio

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

    Augusto Villanueva;Derek Y. Chiang;Pippa Newell;Judit Peix

  • Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

    Daniela Sia;Yang Jiao;Iris Martinez-Quetglas;Olga Kuchuk;Olga Kuchuk

  • Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

    Derek Y. Chiang;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Judit Peix

  • Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

    Elisa Wurmbach;Ying Bei Chen;Greg Khitrov;Weijia Zhang

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.

    Sandro Rossi;Francesco Garbagnati;Riccardo Lencioni;Hans-Peter Allgaier

  • Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.

    Vincenzo Mazzaferro;Sherrie Bhoori;Carlo Sposito;Marco Bongini

Frequent Co-Authors

Josep M. Llovet
Josep M. Llovet University of Barcelona
Jordi Bruix
Jordi Bruix University of Barcelona
Filippo de Braud
Filippo de Braud University of Milan
Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Myron Schwartz
Myron Schwartz Icahn School of Medicine at Mount Sinai
Antonio Daniele Pinna
Antonio Daniele Pinna University of Bologna
Thomas E. Starzl
Thomas E. Starzl University of Pittsburgh
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Luigi Mariani
Luigi Mariani University Hospital of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA offers numerous specialized online degrees and career pathways for those interested in advancing their healthcare careers. For professionals seeking leadership roles in healthcare administration, there are top online mha programs that are cahme accredited. These programs ensure high-quality education and are recognized by employers nationwide.

Registered Nurses looking to further their qualifications can benefit from rn to bsn online no clinicals accredited programs. These courses allow RNs to earn a bachelor's degree conveniently online, often without the need for in-person clinical requirements.

For nurses aiming for advanced practice or leadership positions, pursuing a Doctor of Nursing Practice may be ideal. Options such as shortest dnp programs online help professionals complete their studies faster, while shortest dnp program resources highlight programs designed for flexibility and efficiency.

With these accessible options, students and professionals can find programs that fit their schedules and career ambitions as they explore the field of medicine in the USA.

Best Scientists Citing Vincenzo Mazzaferro

Trending Scientists